Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With Colorectal Cancer

被引:0
|
作者
Kayano, Hajime [1 ]
Mamuro, Nana [1 ]
Kamei, Yutaro [1 ]
Ogimi, Takashi [1 ]
Miyakita, Hiroshi [1 ]
Kanatani, Yasuhiro [2 ]
Mori, Masaki [1 ]
Okada, Kenichi [1 ]
Koyanagi, Kazuo [1 ]
Yamamoto, Seiichiro [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Gastroenterol Surg, Isehara, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa, Japan
关键词
Colon cancer; body composition; perioperative period; skeletal muscle loss; adjuvant chemotherapy; LEAN BODY-MASS; ADJUVANT CHEMOTHERAPY; NUTRITIONAL-STATUS; GASTRIC-CANCER; GASTRECTOMY; SURGERY; DETERMINANT; ILEOSTOMY; ADULTS; S-1;
D O I
10.21873/anticanres.17231
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Postoperative changes in body composition, especially loss of muscle mass, often occur in gastrointestinal cancer patients. Few studies have reported perioperative changes in the body composition of patients with colorectal cancer. Therefore, this study aimed at clarifying changes in body composition during the perioperative period and identifying risk factors for skeletal muscle mass loss in patients with colorectal cancer. Patients and Methods: This prospective observational study included 148 patients who underwent robot- or laparoscopic-assisted surgery for colorectal cancer. Results: The rate of change in body composition at discharge was - 6.25% for body fat, with a higher rate of decrease than that for skeletal muscle mass (-3.30%; - 3.30%; p=0.0006) and body water mass (-2.66%; - 2.66%; p=0.0001). Similarly, even at one month postoperatively, body fat mass (-8.05%) - 8.05%) was reduced at a greater rate than skeletal muscle mass (-2.02% - 2.02% p=0.0001) and body water mass (-1.33% - 1.33% p=0.0001).The site-specific percent change in limb skeletal and trunk muscle mass at discharge was the greatest in the lower extremities at - 5.37%, but one month after surgery, the upper extremities had the greatest change at - 4.44%. The Prognostic Nutritional Index (PNI) influenced skeletal muscle mass loss at discharge [odds ratio (OR)=2.6; 95% confidence interval (CI)=1.30-5.58], while diabetes (OR=4.1; 95%CI=1.40-12.43) and ileostomy (OR=6.7; 95%CI=1.45-31.11) influenced skeletal muscle loss one month postoperatively. Conclusion: Preoperative and postoperative nutritional guidance/intervention and body part-specific rehabilitation should be provided to prevent skeletal muscle mass loss in patients with low PNI, diabetes, and those undergoing ileostomy.
引用
收藏
页码:4019 / 4029
页数:11
相关论文
共 50 条
  • [1] Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer
    Sugiura, Ryo
    Kuwatani, Masaki
    Kawakubo, Kazumichi
    Kishi, Kazuma
    Yonemura, Hiroki
    Nozawa, Shunichiro
    Ohara, Masatsugu
    Noji, Takehiro
    Hirano, Satoshi
    Sakamoto, Naoya
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2024, 31 (08) : 549 - 558
  • [2] Association of Perioperative Skeletal Muscle Index Change With Outcome in Colorectal Cancer Patients
    Li, Zhenhui
    Yan, Guanghong
    Liu, Mengmei
    Li, Yanli
    Liu, Lizhu
    You, Ruimin
    Cheng, Xianshuo
    Zhang, Caixia
    Li, Qingwan
    Jiang, Zhaojuan
    Ruan, Jinqiu
    Ding, Yingying
    Li, Wenliang
    You, Dingyun
    Liu, Zaiyi
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (06) : 2519 - 2535
  • [3] Risk factors for loss of skeletal muscle mass in patients with cirrhosis
    Sung, Ji Hyun
    Uojima, Haruki
    Hidaka, Hisashi
    Tanaka, Yoshiaki
    Wada, Naohisa
    Kubota, Kousuke
    Nakazawa, Takahide
    Shibuya, Akitaka
    Fujikawa, Tomoaki
    Yamanoue, Hiroki
    Kako, Makoto
    Koizumi, Wasaburo
    HEPATOLOGY RESEARCH, 2019, 49 (05) : 550 - 558
  • [4] Factors associated with variability in skeletal muscle radiodensity in patients with metastatic cancer
    Calixto-Lima, Larissa
    Wiegert, Emanuelly Varea Maria
    de Oliveira, Livia Costa
    Chaves, Gabriela Villaca
    Avesani, Carla Maria
    Bezerra, Flavia Fioruci
    NUTRITION, 2024, 120
  • [5] Bidirectional association between perioperative skeletal muscle and subcutaneous fat in colorectal cancer patients and their prognostic significance
    Yan, Guanghong
    Liu, Lizhu
    Liu, Mengmei
    Jiang, Xinyue
    Chen, Ping
    Li, Min
    Ma, Qingyan
    Li, Yani
    Duan, Sifan
    You, Ruimin
    Huang, Yanni
    Li, Zhenhui
    You, Dingyun
    FRONTIERS IN NUTRITION, 2024, 11
  • [6] Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients
    Kurk, Sophie
    Peeters, Petra
    Stellato, Rebecca
    Dorresteijn, B.
    de Jong, Pim
    Jourdan, Marion
    Creemers, Geert-Jan
    Erdkamp, Frans
    de Jongh, Felix
    Kint, Peter
    Simkens, Lieke
    Tanis, Bea
    Tjin-A-Ton, Manuel
    Van Der Velden, Ankie
    Punt, Cornelis
    Koopman, Miriam
    May, Anne
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2019, 10 (04) : 803 - 813
  • [7] Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
    Miyamoto, Yuji
    Baba, Yoshifumi
    Sakamoto, Yasuo
    Ohuchi, Mayuko
    Tokunaga, Ryuma
    Kurashige, Junji
    Hiyoshi, Yukiharu
    Iwagami, Shiro
    Yoshida, Naoya
    Watanabe, Masayuki
    Baba, Hideo
    PLOS ONE, 2015, 10 (06):
  • [8] Perioperative cardiovascular and noncardiovascular risk in patients with colorectal cancer
    Pernicky, M.
    Murin, J.
    Labas, P.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2007, 108 (06): : 246 - 250
  • [9] Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer
    Huemer, Florian
    Schlintl, Verena
    Hecht, Stefan
    Hackl, Hubert
    Melchardt, Thomas
    Rinnerthaler, Gabriel
    Greil, Richard
    Weiss, Lukas
    CLINICAL COLORECTAL CANCER, 2019, 18 (02) : 159 - +
  • [10] Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer
    Yuichiro Nakashima
    Hiroshi Saeki
    Qingjiang Hu
    Yasuo Tsuda
    Yoko Zaitsu
    Yuichi Hisamatsu
    Koji Ando
    Yasue Kimura
    Eiji Oki
    Masaki Mori
    Annals of Surgical Oncology, 2020, 27 : 492 - 498